CNBX Pharmaceuticals Inc. (CNBX): auditor change — CNBX Pharmaceuticals replaces independent auditor with no disagreements

CNBX Pharmaceuticals Inc.

Replaced Weinstein International CPA with Elkana Amitai, CPA effective March 18, 2024.
Auditor change covers fiscal year ended August 31, 2023 and subsequent periods.
No disagreements or reportable events occurred with former auditor during prior fiscal years.
Former accountant's letter attached as Exhibit 16.1; Board approved change on March 18, 2024.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

CNBX Pharmaceuticals Inc. engaged Elkana Amitai, CPA as its auditor.

Action: engagement
Auditor: Elkana Amitai, CPA

Exact text from the filing

CNBX Pharmaceuticals Inc. (the “Company”) has replaced Weinstein International CPA (the “Former Accounting Firm”) as its independent registered public accounting firm, effective as of March 18 th , 2024, and has engaged Elkana Amitai, CPA, Rimon 1, Mitzpe Netofa, Israel (the “New Accounting Firm”) as its new independent registered public accounting firm as of and for the year ended August 31 st , 2023.

View on SEC.gov

Browse all auditor changes →

CNBX Pharmaceuticals Inc. filing history →

Source: SEC EDGAR

accession 0001683168-24-001610

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.